(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl) 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one 204005-46-9 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one D04ADG InSolution&trade Methylene]-2H-indol-2-one S 8442 SU 5416 SU-5416 SU5416 Semaxanib Semaxanib (USAN/INN) Semaxinib Semaxnib Semoxind TSU-16 VEGF Receptor 2 Kinase Inhibitor III CAS 204005-46-9

Purity 97%+In StockPharmaceutical Standards
CAS No.204005-46-9
Molecular FormulaC15H24N2O
Molecular Weight248.36 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl) 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one 204005-46-9 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one D04ADG InSolution&trade Methylene]-2H-indol-2-one S 8442 SU 5416 SU-5416 SU5416 Semaxanib Semaxanib (USAN/INN) Semaxinib Semaxnib Semoxind TSU-16 VEGF Receptor 2 Kinase Inhibitor III CAS 204005-46-9 chemical structure

Description

(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl) 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one 204005-46-9 3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone 3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one 3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one D04ADG InSolution&trade Methylene]-2H-indol-2-one S 8442 SU 5416 SU-5416 SU5416 Semaxanib Semaxanib (USAN/INN) Semaxinib Semaxnib Semoxind TSU-16 VEGF Receptor 2 Kinase Inhibitor III (CAS 204005-46-9) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C15H24N2O. Molecular weight: 248.36 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.

Physical & Chemical Properties

Molecular FormulaC15H24N2O
Molecular Weight248.36 g/mol
Purity97%+
StorageStore at 2-8°C, protect from light
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityLight-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)5.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)2015
Nitrogen Atoms2

Related Z Standards

Recommended Standards

Why CATO?